
Global Blood Glucose Monitoring Lancing Device Market 2025 by Manufacturers, Regions, Type and Application, Forecast to 2031
Description
According to our (Global Info Research) latest study, the global Blood Glucose Monitoring Lancing Device market size was valued at US$ 244 million in 2024 and is forecast to a readjusted size of USD 344 million by 2031 with a CAGR of 5.1% during review period.
Lancing device is an instrument equipped with a lancet. It is also most commonly used by diabetics during blood glucose monitoring. The depth of skin penetration can be adjusted for various skin thicknesses. Long lancing devices are used for fetal scalp blood testing to get a measure of the acid base status of the fetus.
The Lancing Devices market is driven by the increasing prevalence of diabetes and the need for efficient blood glucose monitoring. Lancing devices are essential tools for obtaining blood samples for glucose testing. The rise in diabetes cases and the emphasis on self-management contribute to market growth as individuals seek user-friendly and less painful testing solutions. Moreover, advancements in lancing device technology, including adjustable depth and less invasive mechanisms, align with patient preferences. However, the market also faces challenges, including addressing the discomfort associated with frequent testing and ensuring consistent blood sample quality. Additionally, promoting proper lancing technique and minimizing infection risks can pose obstacles for manufacturers. To succeed, companies must focus on research and development to offer innovative and comfortable lancing devices, collaborate with healthcare professionals for patient education, and address the challenges to meet the increasing demand for accurate and patient-friendly blood glucose monitoring solutions.
This report is a detailed and comprehensive analysis for global Blood Glucose Monitoring Lancing Device market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Blood Glucose Monitoring Lancing Device market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2020-2031
Global Blood Glucose Monitoring Lancing Device market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2020-2031
Global Blood Glucose Monitoring Lancing Device market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2020-2031
Global Blood Glucose Monitoring Lancing Device market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2020-2025
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Blood Glucose Monitoring Lancing Device
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Blood Glucose Monitoring Lancing Device market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Roche, Lifescan, Abbott, Ascensia, B. Braun, TERUMO, Sinocare, ARKRAY, GMMC Group, BIONIME, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Blood Glucose Monitoring Lancing Device market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Adjustable Lancing Device
Non-adjustable Lancing Device
Market segment by Application
Online
Offline
Major players covered
Roche
Lifescan
Abbott
Ascensia
B. Braun
TERUMO
Sinocare
ARKRAY
GMMC Group
BIONIME
LIANFA
Lobeck Medical AG
Market segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Blood Glucose Monitoring Lancing Device product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Blood Glucose Monitoring Lancing Device, with price, sales quantity, revenue, and global market share of Blood Glucose Monitoring Lancing Device from 2020 to 2025.
Chapter 3, the Blood Glucose Monitoring Lancing Device competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Blood Glucose Monitoring Lancing Device breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2020 to 2031.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2020 to 2031.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2020 to 2025.and Blood Glucose Monitoring Lancing Device market forecast, by regions, by Type, and by Application, with sales and revenue, from 2026 to 2031.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Blood Glucose Monitoring Lancing Device.
Chapter 14 and 15, to describe Blood Glucose Monitoring Lancing Device sales channel, distributors, customers, research findings and conclusion.
Lancing device is an instrument equipped with a lancet. It is also most commonly used by diabetics during blood glucose monitoring. The depth of skin penetration can be adjusted for various skin thicknesses. Long lancing devices are used for fetal scalp blood testing to get a measure of the acid base status of the fetus.
The Lancing Devices market is driven by the increasing prevalence of diabetes and the need for efficient blood glucose monitoring. Lancing devices are essential tools for obtaining blood samples for glucose testing. The rise in diabetes cases and the emphasis on self-management contribute to market growth as individuals seek user-friendly and less painful testing solutions. Moreover, advancements in lancing device technology, including adjustable depth and less invasive mechanisms, align with patient preferences. However, the market also faces challenges, including addressing the discomfort associated with frequent testing and ensuring consistent blood sample quality. Additionally, promoting proper lancing technique and minimizing infection risks can pose obstacles for manufacturers. To succeed, companies must focus on research and development to offer innovative and comfortable lancing devices, collaborate with healthcare professionals for patient education, and address the challenges to meet the increasing demand for accurate and patient-friendly blood glucose monitoring solutions.
This report is a detailed and comprehensive analysis for global Blood Glucose Monitoring Lancing Device market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Blood Glucose Monitoring Lancing Device market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2020-2031
Global Blood Glucose Monitoring Lancing Device market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2020-2031
Global Blood Glucose Monitoring Lancing Device market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2020-2031
Global Blood Glucose Monitoring Lancing Device market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2020-2025
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Blood Glucose Monitoring Lancing Device
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Blood Glucose Monitoring Lancing Device market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Roche, Lifescan, Abbott, Ascensia, B. Braun, TERUMO, Sinocare, ARKRAY, GMMC Group, BIONIME, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Blood Glucose Monitoring Lancing Device market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Adjustable Lancing Device
Non-adjustable Lancing Device
Market segment by Application
Online
Offline
Major players covered
Roche
Lifescan
Abbott
Ascensia
B. Braun
TERUMO
Sinocare
ARKRAY
GMMC Group
BIONIME
LIANFA
Lobeck Medical AG
Market segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Blood Glucose Monitoring Lancing Device product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Blood Glucose Monitoring Lancing Device, with price, sales quantity, revenue, and global market share of Blood Glucose Monitoring Lancing Device from 2020 to 2025.
Chapter 3, the Blood Glucose Monitoring Lancing Device competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Blood Glucose Monitoring Lancing Device breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2020 to 2031.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2020 to 2031.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2020 to 2025.and Blood Glucose Monitoring Lancing Device market forecast, by regions, by Type, and by Application, with sales and revenue, from 2026 to 2031.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Blood Glucose Monitoring Lancing Device.
Chapter 14 and 15, to describe Blood Glucose Monitoring Lancing Device sales channel, distributors, customers, research findings and conclusion.
Table of Contents
122 Pages
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.